opana

FDA Requests Opioid Painkiller Be Removed From The Market, Citing Abuse Risks, HIV Outbreak

FDA Requests Opioid Painkiller Be Removed From The Market, Citing Abuse Risks, HIV Outbreak

The Food and Drug Administration has asked Endo Pharmaceuticals, the manufacturer of Opana ER, an extended-release semi-synthetic opioid painkiller, to remove the drug from the market, after the agency concluded that the drug’s potential for abuse outweighed its therapeutic value. [More]